Targeted disruption of the heat shock protein 20-phosphodiesterase 4D (PDE4D) interaction protects against pathological cardiac remodelling in a mouse model of hypertrophy

FEBS Open Bio

Volumn 4, Issue , 2014, Pages 923-927

  Martin, Tamara P ^a   Hortigon Vinagre, Maria P ^a   Findlay, Jane E ^a   Elliott, Christina ^a   Currie, Susan ^b   Baillie, George S ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

CAMP; Cardiac hypertrophy; Cardiac remodeling; HSP20; PDE4D; Peptide disruption

Indexed keywords

HEAT SHOCK PROTEIN 20; PHOSPHODIESTERASE IV;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FIBROSING ALVEOLITIS; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING;

EID: 84918518593     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2014.10.011     Document Type: Article

References (21)

1. An S.S., Askovich P.S., Zarembinski T.I., Ahn K., Peltier J.M., von Rechenberg M., Sahasrabudhe S., Fredberg J.J. A novel small molecule target in human airway smooth muscle for potential treatment of obstructive lung diseases: a staged high-throughput biophysical screening. Respir. Res. 2011, 12:8.
2. Fan G.C., Chu G., Kranias E.G. Hsp20 and its cardioprotection. Trends Cardiovasc. Med. 2005, 15:138-141.
3. Edwards H.V., Cameron R.T., Baillie G.S. The emerging role of HSP20 as a multifunctional protective agent. Cell Signal. 2011, 23:1447-1454.
4. Edwards H.V., Scott J.D., Baillie G.S. PKA phosphorylation of the small heat-shock protein Hsp20 enhances its cardioprotective effects. Biochem. Soc. Trans. 2012, 40:210-214.
5. Wang X., Zingarelli B., O'Connor M., Zhang P., Adeyemo A., Kranias E.G., Wang Y., Fan G.C. Overexpression of Hsp20 prevents endotoxin-induced myocardial dysfunction and apoptosis via inhibition of NF-kappaB activation. J. Mol. Cell. Cardiol. 2009, 47:382-390.
6. McLemore E.C., Tessier D.J., Flynn C.R., Furnish E.J., Komalavilas P., Thresher J.S., Joshi L., Stone W.M., Fowl R.J., Brophy C.M. Transducible recombinant small heat shock-related protein, HSP20, inhibits vasospasm and platelet aggregation. Surgery 2004, 136:573-578.
7. Baillie G.S. Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases. FEBS J. 2009, 276:1790-1799.
8. McCormick K., Baillie G.S. Compartmentalisation of second messenger signalling pathways. Curr. Opin. Genet. Dev. 2014, 27C:20-25.
9. Tomita H., Nazmy M., Kajimoto K., Yehia G., Molina C.A., Sadoshima J. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation. Circ. Res. 2003, 93:12-22.
10. Lee L.C., Maurice D.H., Baillie G.S. Targeting protein-protein interactions within the cyclic AMP signaling system as a therapeutic strategy for cardiovascular disease. Future Med. Chem. 2013, 5:451-464.
11. Sin Y.Y., Edwards H.V., Li X., Day J.P., Christian F., Dunlop A.J., Adams D.R., Zaccolo M., Houslay M.D., Baillie G.S. Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the beta-agonist induced hypertrophic response in cardiac myocytes. J. Mol. Cell. Cardiol. 2011, 50:872-883.
12. Edwards H.V., Scott J.D., Baillie G.S. The A-kinase-anchoring protein AKAP-Lbc facilitates cardioprotective PKA phosphorylation of Hsp20 on Ser(16). Biochem. J. 2012, 446:437-443.
13. Martin T.P., Robinson E., Harvey A.P., MacDonald M., Grieve D.J., Paul A., Currie S. Surgical optimization and characterization of a minimally invasive aortic banding procedure to induce cardiac hypertrophy in mice. Exp. Physiol. 2012, 97:822-832.
14. Junqueira L.C., Bignolas G., Brentani R.R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J. 1979, 11:447-455.
15. Szentandrassy N., Farkas V., Barandi L., Hegyi B., Ruzsnavszky F., Horvath B., Banyasz T., Magyar J., Marton I., Nanasi P.P. Role of action potential configuration and the contribution of C(2)(+)a and K(+) currents to isoprenaline-induced changes in canine ventricular cells. Br. J. Pharmacol. 2012, 167:599-611.
16. Qian J., Vafiadaki E., Florea S.M., Singh V.P., Song W., Lam C.K., Wang Y., Yuan Q., Pritchard T.J., Cai W., Haghighi K., Rodriguez P., Wang H.S., Sanoudou D., Fan G.C., Kranias E.G. Small heat shock protein 20 interacts with protein phosphatase-1 and enhances sarcoplasmic reticulum calcium cycling. Circ. Res. 2011, 108:1429-1438.
17. Fan G.C., Yuan Q., Song G., Wang Y., Chen G., Qian J., Zhou X., Lee Y.J., Ashraf M., Kranias E.G. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1. Circ. Res. 2006, 99:1233-1242.
18. Schweikart K., Guo L., Shuler Z., Abrams R., Chiao E.T., Kolaja K.L., Davis M. The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activity. Toxicol. In Vitro 2013, 27:745-751.
19. Moreo A., Ambrosio G., De Chiara B., Pu M., Tran T., Mauri F., Raman S.V. Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ. Cardiovasc. Imaging 2009, 2:437-443.
20. Lopes L.B., Furnish E.J., Komalavilas P., Flynn C.R., Ashby P., Hansen A., Ly D.P., Yang G.P., Longaker M.T., Panitch A., Brophy C.M. Cell permeant peptide analogues of the small heat shock protein, HSP20, reduce TGF-beta1-induced CTGF expression in keloid fibroblasts. J. Invest. Dermatol. 2009, 129:590-598.
21. Dreiza C.M., Brophy C.M., Komalavilas P., Furnish E.J., Joshi L., Pallero M.A., Murphy-Ullrich J.E., von Rechenberg M., Ho Y.S., Richardson B., Xu N., Zhen Y., Peltier J.M., Panitch A. Transducible heat shock protein 20 (HSP20) phosphopeptide alters cytoskeletal dynamics. FASEB J. 2005, 19:261-263.